We read with great interest the article by Ou et al. [
[1]
] and find certain important points remain untouched.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Obstetrics and Gynecology and Reproductive BiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Management of patients with placenta accreta spectrum disorders who underwent pregnancy terminations in the second trimester: a retrospective study.Eur J Obstet Gynecol Reprod Biol. 2019; 242: 109-113
- Management strategies for patients with placenta accreta spectrum disorders who underwent pregnancy termination in the second trimester: a retrospective study.BMC Pregnancy Childbirth. 2018; 18: 298
- Comparison of selective and non-selective internal iliac artery embolization for abnormal placentation with major postpartum hemorrhage.Int J Gynaecol Obstet. 2017; 136: 103-104
- In reply to letter to the editor: methotrexate and uterine artery embolization for placenta accreta spectrum disorders: some clarifications.Clin Radiol. 2019; 74: 647-648
- Planned conservative management of placenta accreta – experience of a regional general hospital.J Matern-Fetal Neonatal Med. 2014; 27: 291-296
Article info
Publication history
Published online: November 07, 2019
Received:
October 19,
2019
Identification
Copyright
© 2019 Elsevier B.V. All rights reserved.
